2017-08-11_12-15-27

What will we learn and who will we meet at USCA 2017?

While recent advancements in medicine are transforming HIV treatment, patients still need personalized medication management programs to ensure all that can be done is being done to keep viral loads low or achieve suppression.

If you share this goal, we want to connect at USCA 2017. Visit us at booth #315.

We are all living in incredibly exciting times in the advancement of treatment for HIV and AIDS. Here are just a few headlines that really got our attention:

“For first time in history, half of all people with HIV are getting treatment”

Sciencemag.org

“Monthly shot could be the ‘next revolution’ in HIV therapy, replacing daily pills”

Washington Post

“Scientists Report Encouraging HIV Treatment, Vaccine Research Findings At IAS 2017 Conference”

The Kaiser Family Foundation

Looking forward through this lense of optimism the team at Curant Health will seek to learn from, and share our insights with, leaders in HIV and AIDS therapy at the 2017 United States Conference on AIDS (USCA 2017).

We know there is a huge amount of work yet to be done to improve access to therapy and provide critical patient support for patients with HIV and AIDS. But we at Curant Health take heart in the remarkable advancements in medicine, including pharmaceutical therapies, that have transformed a disease once a death sentence to a highly manageable chronic condition.

If you are a provider of healthcare services for HIV and AIDS patients, be it a case manager, clinical team lead or clinician [other ‘type of person’ to add?], we want to meet with you at USCA 2017. Our value-based HIV treatment program provides personalized care and is proven to improve outcomes while reducing partners’ cost of care. Curant Health also offers the most robust, compliant 340B program available focusing on increasing medication adherence and improving patient outcomes.

You can find us at booth # 315. To set up a meeting in advance, contact Health System Manager, Amber Adams at aadams@curanthealth.com.

2016-09-02_8-49-54
ROBERT

“Presenting with a CD4 count of only 21, doctors gave Robert months to live. Weighing 98 pounds, his HIV had progressed to Stage 3 AIDS. Though he wanted to get better, he had to make decisions on which medications to buy based on what he could afford.

Complicating Robert’s case was the fact that he had developed coronary artery disease and needed a bypass. However, surgeons could not consider him a candidate for the procedure until his HIV viral load became undetectable.

Read more on Robert’s personalized medication management program.

TIM

Jim Vollman, the HIV Program Director for The Living Bridge, a Ryan White entity in North Georgia, met Tim when he was 22-years-old. Tim had been diagnosed with HIV two years earlier, in April 2008 and bipolar disorder and schizophrenia in June of the same year.

One complicating factor for Tim was his complete aversion to taking pills. Vollman and his staff eventually discovered in early 2009 that Tim had not been taking his HIV medications for nearly a year. One complicating factor for Tim was a complete aversion to taking pills.

Read more on Curant Health’s personalized medication management program for Tim.

a

The USCA 2017 website has all the information an attendee could need including the program and a nifty conference app for download. What will we all learn? Who will we meet? Let’s connect! Again, contact Amber Adams at aadams@curanthealth.com.

Follow Us!

Follow Curant Health on Twitter and LinkedIn for our take on the USCA 2017 Conference and other events where HIV medication management and healthcare industry leaders connect. 

 
EmailEmailEmailEmail
Menu Title